Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients

Scand Cardiovasc J. 2007 Oct;41(5):287-93. doi: 10.1080/14017430701481963.

Abstract

Objectives: To compare management and outcome of female and male non-ST-elevation acute coronary syndrome (ACS) patients.

Design: FINACS Studies are prospective registries of non-ST-elevation ACS patients conducted in 2001, 2003, and 2005 in nine hospitals.

Results: The studies enrolled 1,399 patients from which 39% were women. During hospitalisation women were treated less often than men with aspirin (odds ratio [OR]) for women 0.60, 95% confidence interval [CI] 0.41 to 0.88, p=0.03). Women underwent less often in-hospital coronary angiography than men (adjusted OR 0.71, 95% CI 0.55 to 0.93, p=0.01). Also in the subgroup of younger (<75 years) high-risk patients, female sex was independent predictor for not performing in-hospital angiography (OR 0.64, 95% CI 0.42 to 0.97, p=0.04). Age-adjusted mortality at 6 months was similar between men and women.

Conclusions: Compared to men women received less often aspirin. Women were referred less often to in-hospital coronary angiography. Under-use of in-hospital angiography was evident also in patients with high-risk features when guidelines recommend early invasive treatment.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome / diagnosis
  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / mortality
  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Aspirin / therapeutic use*
  • Coronary Angiography / statistics & numerical data
  • Female
  • Finland / epidemiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prospective Studies
  • Registries
  • Risk Factors
  • Sex Factors
  • Survival Analysis

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Aspirin